Vishaal Mehra MD

Psychiatry•San Diego, CA

CEO/ Medical Director, Artemis Institute for Clinical Research

Join to View Full Profile

770 Washington StSuite 200San Diego, CA 92103
Phone+1 858-278-3647
Fax+1 858-278-3660

Education & Training

University of California (San Diego) Medical CenterResidency, Psychiatry, 2001 - 2005
Texas A&M; Health Science Center College of MedicineClass of 2000

Certifications & Licensure

CA State Medical License 2002 - 2026
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder Start of enrollment: 2008 Sep 01
Terminated
Phase 2
Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression Start of enrollment: 2011 May 01
Completed
Phase 2
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose Start of enrollment: 2011 Sep 01
Completed
Phase 3
Major Depressive Disorder With Mixed Features - Extension Start of enrollment: 2011 Sep 01
Completed
Phase 3
Open-label Safety Study in Adults With ADHD Start of enrollment: 2014 Jun 01
Completed
Phase 3
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache Start of enrollment: 2014 Jul 07
Completed
Phase 2
Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder Start of enrollment: 2015 Jul 27
Completed
Phase 3
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD Start of enrollment: 2016 Jan 01
Completed
Not Applicable
Improving Office Based Treatment of Opioid Use Disorder With Technology Start of enrollment: 2018 Dec 01
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

43 citations
Effects of monthly buprenorphine extended-release injections on patient-centered outcomes: A long-term study.
Walter Ling, Vijay R Nadipelli, Caitlyn T. Solem, Naoko A Ronquest, Yu-Chen Yeh
Journal of Substance Abuse Treatment. 2020-03-01
11 citations
Remission from chronic opioid use-Studying environmental and socio-economic factors on recovery (RECOVER): Study design and participant characteristics.
Walter Ling, Vijay R Nadipelli, Naoko A Ronquest, Victoria A Albright, Arnie Aldridge
Contemporary Clinical Trials. 2019-01-01
130 citations
Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility.
Paul Bradley, Michael Shiekh, Vishaal Mehra, Keith Vrbicky, Stacey Layle
Journal of Psychiatric Research. 2018-01-01